These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 10668685)

  • 1. Stroke in patients with heart failure and reduced left ventricular ejection fraction.
    Pullicino PM; Halperin JL; Thompson JL
    Neurology; 2000 Jan; 54(2):288-94. PubMed ID: 10668685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological prevention of thromboembolism in patients with left ventricular dysfunction.
    Thatai D; Ahooja V; Pullicino PM
    Am J Cardiovasc Drugs; 2006; 6(1):41-9. PubMed ID: 16489847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left Ventricular Ejection Fraction and Risk of Stroke and Cardiac Events in Heart Failure: Data From the Warfarin Versus Aspirin in Reduced Ejection Fraction Trial.
    Di Tullio MR; Qian M; Thompson JL; Labovitz AJ; Mann DL; Sacco RL; Pullicino PM; Freudenberger RS; Teerlink JR; Graham S; Lip GY; Levin B; Mohr JP; Buchsbaum R; Estol CJ; Lok DJ; Ponikowski P; Anker SD; Homma S;
    Stroke; 2016 Aug; 47(8):2031-7. PubMed ID: 27354224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent stroke in the warfarin versus aspirin in reduced cardiac ejection fraction (WARCEF) trial.
    Pullicino PM; Qian M; Sacco RL; Freudenberger R; Graham S; Teerlink JR; Mann D; Di Tullio MR; Ponikowski P; Lok DJ; Anker SD; Lip GY; Estol CJ; Levin B; Mohr JP; Thompson JL; Homma S;
    Cerebrovasc Dis; 2014; 38(3):176-81. PubMed ID: 25300706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of anticoagulation control in preventing adverse events in patients with heart failure in sinus rhythm: Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction trial substudy.
    Homma S; Thompson JL; Qian M; Ye S; Di Tullio MR; Lip GY; Mann DL; Sacco RL; Levin B; Pullicino PM; Freudenberger RS; Teerlink JR; Graham S; Mohr JP; Labovitz AJ; Buchsbaum R; Estol CJ; Lok DJ; Ponikowski P; Anker SD;
    Circ Heart Fail; 2015 May; 8(3):504-9. PubMed ID: 25850425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombotics in heart failure with reduced ejection fraction and normal sinus rhythm: an evidence appraisal.
    Prom R; Usedom JE; Dull RB
    Ann Pharmacother; 2014 Feb; 48(2):226-37. PubMed ID: 24259641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Warfarin versus aspirin in patients with reduced cardiac ejection fraction (WARCEF): rationale, objectives, and design.
    Pullicino P; Thompson JL; Barton B; Levin B; Graham S; Freudenberger RS;
    J Card Fail; 2006 Feb; 12(1):39-46. PubMed ID: 16500579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial.
    Massie BM; Collins JF; Ammon SE; Armstrong PW; Cleland JG; Ezekowitz M; Jafri SM; Krol WF; O'Connor CM; Schulman KA; Teo K; Warren SR;
    Circulation; 2009 Mar; 119(12):1616-24. PubMed ID: 19289640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac resynchronization therapy in chronic heart failure with moderately reduced left ventricular ejection fraction: Lessons from the Multicenter InSync Randomized Clinical Evaluation MIRACLE EF study.
    Linde C; Curtis AB; Fonarow GC; Lee K; Little W; Tang A; Levya F; Momomura S; Manrodt C; Bergemann T; Cowie MR
    Int J Cardiol; 2016 Jan; 202():349-55. PubMed ID: 26426276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bleeding Risk and Antithrombotic Strategy in Patients With Sinus Rhythm and Heart Failure With Reduced Ejection Fraction Treated With Warfarin or Aspirin.
    Ye S; Cheng B; Lip GY; Buchsbaum R; Sacco RL; Levin B; Di Tullio MR; Qian M; Mann DL; Pullicino PM; Freudenberger RS; Teerlink JR; Mohr JP; Graham S; Labovitz AJ; Estol CJ; Lok DJ; Ponikowski P; Anker SD; Thompson JL; Homma S;
    Am J Cardiol; 2015 Sep; 116(6):904-12. PubMed ID: 26189039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation of left ventricular ejection fraction and clinical features or co-morbidities to outcomes among patients hospitalized for acute heart failure syndromes.
    Kajimoto K; Sato N; Takano T;
    Am J Cardiol; 2015 Feb; 115(3):334-40. PubMed ID: 25476557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients with left ventricular ejection fraction greater than 58 % have fewer incidences of future acute decompensated heart failure admission and all-cause mortality.
    Goto T; Wakami K; Fukuta H; Fujita H; Tani T; Ohte N
    Heart Vessels; 2016 May; 31(5):734-43. PubMed ID: 25771802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Cardiac Resynchronization Therapy on Cardiac Remodeling and Contractile Function: Results From Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE).
    St John Sutton M; Cerkvenik J; Borlaug BA; Daubert C; Gold MR; Ghio S; Chirinos JA; Linde C; Ky B
    J Am Heart Assoc; 2015 Sep; 4(9):e002054. PubMed ID: 26363005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. To anticoagulate or not to anticoagulate patients with cardiomyopathy.
    Graham SP
    Cardiol Clin; 2001 Nov; 19(4):605-15. PubMed ID: 11715181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type 2 diabetes and heart failure: Characteristics and prognosis in preserved, mid-range and reduced ventricular function.
    Johansson I; Dahlström U; Edner M; Näsman P; Rydén L; Norhammar A
    Diab Vasc Dis Res; 2018 Nov; 15(6):494-503. PubMed ID: 30176743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of ejection fraction (or lack thereof), morbidity/mortality and heart failure drug trials: a review.
    Fogel MA
    Int J Cardiol; 2002 Aug; 84(2-3):119-32. PubMed ID: 12127364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of anemia and renal dysfunction with in-hospital mortality among patients hospitalized for acute heart failure syndromes with preserved or reduced ejection fraction.
    Kajimoto K; Sato N; Takano T;
    Eur Heart J Acute Cardiovasc Care; 2016 Nov; 5(7):89-99. PubMed ID: 26124457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response by Di Tullio et al to Letter Regarding Article, "Left Ventricular Ejection Fraction and Risk of Stroke and Cardiac Events in Heart Failure: Data From the Warfarin Versus Aspirin in Reduced Ejection Fraction Trial".
    Di Tullio MR; Thompson JL; Homma S;
    Stroke; 2016 Dec; 47(12):e273. PubMed ID: 27803390
    [No Abstract]   [Full Text] [Related]  

  • 19. Three year mortality in heart failure patients with very low left ventricular ejection fractions.
    Niebauer J; Clark AL; Anker SD; Coats AJ
    Int J Cardiol; 1999 Aug; 70(3):245-7. PubMed ID: 10501338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Letter by Chen et al Regarding Article, "Left Ventricular Ejection Fraction and Risk of Stroke and Cardiac Events in Heart Failure: Data From the Warfarin Versus Aspirin in Reduced Ejection Fraction Trial".
    Chen C; Li D; Deng L
    Stroke; 2016 Dec; 47(12):e272. PubMed ID: 27803389
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.